martes, 2 de junio de 2020

At ASCO, AstraZeneca does a star turn and KRAS fizzles

At ASCO, AstraZeneca does a star turn and KRAS fizzles

Daily Recap



STAT Plus: ASCO 2020 takeaways: AstraZeneca does a star turn, KRAS fizzles, and cell therapy shows progress

By ADAM FEUERSTEIN


ALEX HOGAN/STAT
Key takeaways from this year's virtual ASCO conference: AstraZeneca does a star turn, KRAS fizzles, and cell therapy shows progress.

No hay comentarios: